Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
22.01
-0.87 (-3.80%)
At close: Oct 21, 2026, 4:00 PM EDT
22.20
+0.19 (0.86%)
After-hours: Oct 21, 2026, 6:48 PM EDT
Structure Therapeutics Employees
Structure Therapeutics had 281 employees as of June 30, 2026. The number of employees increased by 82 or 41.21% compared to the same quarter last year. That makes Structure Therapeutics the 24,361st largest employer in the world and 3,123rd in the United States.
Employees
281
Change (1Y)
82
Growth (1Y)
41.21%
Revenue / Employee
n/a
Profits / Employee
-$764,537
Market Cap
1.57B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 281 | 82 | 41.21% |
| Mar 31, 2026 | 233 | 50 | 27.32% |
| Dec 31, 2025 | 220 | 57 | 34.97% |
| Sep 30, 2025 | 218 | 70 | 47.30% |
| Jun 30, 2025 | 199 | 63 | 46.32% |
| Mar 31, 2025 | 183 | 72 | 64.86% |
| Dec 31, 2024 | 163 | 70 | 75.27% |
| Sep 30, 2024 | 148 | 61 | 70.11% |
| Jun 30, 2024 | 136 | 59 | 76.62% |
| Mar 31, 2024 | 111 | 43 | 63.24% |
| Dec 31, 2023 | 93 | 25 | 36.76% |
| Sep 30, 2023 | 87 | 15 | 20.83% |
| Jun 30, 2023 | 77 | 5 | 6.94% |
| Mar 31, 2023 | 68 | - | - |
| Dec 31, 2022 | 68 | - | - |
| Sep 30, 2022 | 72 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Nuvation Bio | 305 |
| uniQure | 221 |
| Stoke Therapeutics | 170 |
| Innoviva | 159 |
| Maze Therapeutics | 141 |
| Mesoblast | 108 |
GPCR News
- 2 days ago - Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2026 - GlobeNewsWire
- 5 weeks ago - Structure Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 5 weeks ago - Structure Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 6 weeks ago - Structure weakness ‘disconnected’ from underlying data, says Jefferies - TheFly
- 6 weeks ago - Structure obesity portfolio updates ‘encouraging,’ says Clear Street - TheFly
- 6 weeks ago - Structure Therapeutics reports ACCG-2671, aleniglipron trial results - TheFly
- 6 weeks ago - Structure Therapeutics Transcript: Study result - Transcripts
- 6 weeks ago - Structure Therapeutics Press release: Study result - Filings